English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The Effect of Pegvisomant on Cardiovascular Risk in Patients with Active Acromegaly in Comparison to Matched Data from the General Population

MPS-Authors

Stalla,  G. K.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Berg, C., Petersenn, S., Lahner, H., Herrmann, B. L., Buchfelder, M., Droste, M., et al. (2010). The Effect of Pegvisomant on Cardiovascular Risk in Patients with Active Acromegaly in Comparison to Matched Data from the General Population. Endocrine Reviews, 31(3 Suppl. 1), S857-S857.


Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9048-5
Abstract
There is no abstract available